To determine how this pVHL172 enrichment in some tumoral cell may affect tumor development, we stably expressed pVHL172 in 786-O cells (derived from a human primary clear cell renal adenocarcinoma: pVHL null cells). Here, VHL is linked to clear cell renal carcinoma.